Hematology, Transfusion and Cell Therapy (Nov 2020)
RESULTS OF THE PEGASUS PHASE 3 RANDOMIZED TRIAL DEMONSTRATING SUPERIORITY OF THE C3 INHIBITOR PEGCETACOPLAN COMPARED TO ECULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
- H. Weitz,
- P. Hillmen,
- J. Szer,
- A. Röth,
- B. Höchsmann,
- J. Panse,
- K. Usuki,
- M. Griffin,
- J. Kiladjian,
- C. Decastro,
- H. Nishimori,
- L. Tan,
- M. Hamdani,
- P. Deschatelets,
- C. Francois,
- F. Grossi,
- A. Risitano,
- R.P. Latour
Affiliations
- H. Weitz
- Jane Anne Nohl Division of Hematology, Keck-USC School of Medicine, Los Angeles, United States
- P. Hillmen
- Department of Haematology, St James's University Hospital, Leeds, United Kingdom
- J. Szer
- Department of Clinical Haematology, Peter MacCallum Cancer Centre & Royal Melbourne Hospital, Melbourne, Australia
- A. Röth
- Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
- B. Höchsmann
- Institute of Transfusion Medicine, University of Ulm and Institute of Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service and University Hospital Ulm, Ulm, Germany
- J. Panse
- Department of Oncology, Hematology, Hemostaseology and Stem Cell Transplantation, University Hospital RWTH Aachen, Aachen, Germany; NTT Medical Center Tokyo, Tokyo, Japan
- K. Usuki
- Centre d’Investigations Cliniques, Hôpital Saint-Louis; Assistance Publique–Hôpitaux de Paris; Université de Paris, Paris, France
- M. Griffin
- Department of Haematology, St James's University Hospital, Leeds, United Kingdom
- J. Kiladjian
- Centre d’Investigations Cliniques, Hôpital Saint-Louis; Assistance Publique–Hôpitaux de Paris; Université de Paris, Paris, France
- C. Decastro
- Duke University School of Medicine, Durham, United States
- H. Nishimori
- Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan
- L. Tan
- Lisa Tan Pharma Consulting Ltd, Cambridge, United Kingdom
- M. Hamdani
- Apellis Pharmaceuticals, Waltham, United States
- P. Deschatelets
- Apellis Pharmaceuticals, Waltham, United States
- C. Francois
- Apellis Pharmaceuticals, Waltham, United States
- F. Grossi
- Apellis Pharmaceuticals, Waltham, United States
- A. Risitano
- Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy
- R.P. Latour
- French Reference Center for Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria, Assistance Publique–Hôpitaux de Paris, Université de Paris, Paris, France
- Journal volume & issue
-
Vol. 42
pp. 12 – 13
